Controlled clinical trial of a new antidepressant (Org. GB 94) of novel chemical formulation.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000639:Amitriptyline / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D003984:Dibenzazepines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008803:Mianserin / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D010919:Placebos; D013997:Time Factors
D003984:Dibenzazepines; D010919:Placebos; D000639:Amitriptyline; D008803:Mianserin